Yanqiu Gu

1.1k total citations
34 papers, 877 citations indexed

About

Yanqiu Gu is a scholar working on Molecular Biology, Pharmacology and Hepatology. According to data from OpenAlex, Yanqiu Gu has authored 34 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Pharmacology and 10 papers in Hepatology. Recurrent topics in Yanqiu Gu's work include Liver physiology and pathology (9 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Yanqiu Gu is often cited by papers focused on Liver physiology and pathology (9 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). Yanqiu Gu collaborates with scholars based in China, Hong Kong and United Kingdom. Yanqiu Gu's co-authors include Yongfang Yuan, Xiaofei Chen, Shengnan Li, Rong Wang, Yifeng Chai, Fuxing Song, Bin Wu, Lei Lv, Chun Chen and Zhenyu Zhu and has published in prestigious journals such as Advanced Functional Materials, Analytical Chemistry and Science Advances.

In The Last Decade

Yanqiu Gu

31 papers receiving 870 citations

Peers

Yanqiu Gu
Yanqin Bian China
Shuang Ren China
Mohamed E. Shaker Egypt
Hozeifa Mohamed Hassan China
Wenwen Wang China
Hyun Mi Choi South Korea
Honghong Liu China
Junzhe Zhang China
Pengtao You China
Xiaohan Zhai China
Yanqin Bian China
Yanqiu Gu
Citations per year, relative to Yanqiu Gu Yanqiu Gu (= 1×) peers Yanqin Bian

Countries citing papers authored by Yanqiu Gu

Since Specialization
Citations

This map shows the geographic impact of Yanqiu Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqiu Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqiu Gu more than expected).

Fields of papers citing papers by Yanqiu Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanqiu Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqiu Gu. The network helps show where Yanqiu Gu may publish in the future.

Co-authorship network of co-authors of Yanqiu Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanqiu Gu. A scholar is included among the top collaborators of Yanqiu Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanqiu Gu. Yanqiu Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chun, Yanqiu Gu, Chengliang Wang, et al.. (2025). Cell-free synthesis of membrane receptors for preparation of NKG2A monolithic micro-affinity chromatography. Journal of Chromatography A. 1746. 465775–465775.
2.
3.
Fang, Fan, Xu‐Man Chen, Meiyu Lin, et al.. (2024). Peptide‐Based Organic‐Inorganic Hybrid Self‐Assemblies for Ultrasensitive and Visual Detection of Heparin (Adv. Funct. Mater. 22/2024). Advanced Functional Materials. 34(22). 2 indexed citations
4.
Gu, Yanqiu, Fang Fan, Yue Liu, et al.. (2023). Cell-free protein synthesis system for bioanalysis: Advances in methods and applications. TrAC Trends in Analytical Chemistry. 161. 117015–117015. 13 indexed citations
5.
Dong, Yaping, Shuzhen Chen, Zhuoran Sun, et al.. (2023). Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice. Acta Pharmacologica Sinica. 44(7). 1429–1441. 17 indexed citations
6.
Fan, Fang, Xu‐Man Chen, Meiyu Lin, et al.. (2023). Peptide‐Based Organic‐Inorganic Hybrid Self‐Assemblies for Ultrasensitive and Visual Detection of Heparin. Advanced Functional Materials. 34(22). 14 indexed citations
7.
Chen, Panpan, Rong Wang, Shengnan Li, et al.. (2023). Schizandrin C regulates lipid metabolism and inflammation in liver fibrosis by NF-κB and p38/ERK MAPK signaling pathways. Frontiers in Pharmacology. 14. 1092151–1092151. 15 indexed citations
8.
Li, Shengnan, Panpan Chen, Yanqiu Gu, et al.. (2023). Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ. International Immunopharmacology. 122. 110550–110550. 10 indexed citations
9.
Gu, Yanqiu, et al.. (2023). Herbal medicines for insomnia through regulating 5-hydroxytryptamine receptors: a systematic review. Chinese Journal of Natural Medicines. 21(7). 483–498. 19 indexed citations
10.
Wang, Rong, Shengnan Li, Panpan Chen, et al.. (2022). Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR. Phytomedicine. 107. 154435–154435. 24 indexed citations
11.
Gu, Yanqiu, Lei Lv, Chun Chen, et al.. (2022). Screening of immune cell activators from Astragali Radix using a comprehensive two-dimensional NK-92MI cell membrane chromatography/C18 column/time-of-flight mass spectrometry system. Journal of Pharmaceutical Analysis. 12(5). 725–732. 45 indexed citations
12.
Gu, Yanqiu, Rong Wang, Panpan Chen, et al.. (2022). In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography. Acta Pharmaceutica Sinica B. 12(9). 3682–3693. 36 indexed citations
13.
Li, Xiaoqun, Lipeng Wang, Biaotong Huang, et al.. (2020). Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss. Science Advances. 6(47). 77 indexed citations
14.
Zhi, Xin, Chao Fang, Yanqiu Gu, et al.. (2020). Guaiacol suppresses osteoclastogenesis by blocking interactions of RANK with TRAF6 and C‐Src and inhibiting NF‐κB, MAPK and AKT pathways. Journal of Cellular and Molecular Medicine. 24(9). 5122–5134. 15 indexed citations
15.
Chen, Huiwen, Chao Fang, Xin Zhi, et al.. (2020). Neobavaisoflavone inhibits osteoclastogenesis through blocking RANKL signalling‐mediated TRAF6 and c‐Src recruitment and NF‐κB, MAPK and Akt pathways. Journal of Cellular and Molecular Medicine. 24(16). 9067–9084. 56 indexed citations
16.
Gu, Yanqiu, Xiao Chen, Yao Wang, et al.. (2020). Development of 3-mercaptopropyltrimethoxysilane (MPTS)-modified bone marrow mononuclear cell membrane chromatography for screening anti-osteoporosis components from Scutellariae Radix. Acta Pharmaceutica Sinica B. 10(10). 1856–1865. 41 indexed citations
17.
Liu, Yue, Xiaoyu Wang, Yanqiu Gu, et al.. (2020). Covalent Design of Cell Membrane Stationary Phase with Enhanced Stability for Fast Screening P-Glycoprotein Inhibitors. ACS Applied Bio Materials. 3(8). 5000–5006. 13 indexed citations
18.
Li, Shengnan, Rong Wang, Bin Wu, et al.. (2019). Salvianolic acid B protects against ANIT-induced cholestatic liver injury through regulating bile acid transporters and enzymes, and NF-κB/IκB and MAPK pathways. Naunyn-Schmiedeberg s Archives of Pharmacology. 392(9). 1169–1180. 19 indexed citations
19.
20.
Gu, Yanqiu, Xiaofei Chen, Rong Wang, et al.. (2018). Comparative two-dimensional HepG2 and L02/ cell membrane chromatography/ C18/ time-of-flight mass spectrometry for screening selective anti-hepatoma components from Scutellariae Radix. Journal of Pharmaceutical and Biomedical Analysis. 164. 550–556. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanqin Bian Breakdown of academic impact, for papers by Shuang Ren Breakdown of academic impact, for papers by Mohamed E. Shaker Breakdown of academic impact, for papers by Hozeifa Mohamed Hassan Breakdown of academic impact, for papers by Wenwen Wang Breakdown of academic impact, for papers by Hyun Mi Choi Breakdown of academic impact, for papers by Honghong Liu Breakdown of academic impact, for papers by Junzhe Zhang Breakdown of academic impact, for papers by Pengtao You Breakdown of academic impact, for papers by Xiaohan Zhai
Rankless by CCL
2026